Комбинированное применение стабильных имплантатов и хемоденервации при инконтиненции у детей с миелодисплазией

Демидов Александр Александрович, Млынчик Елена Вячеславовна · Russian Journal of Pediatric Surgery · 2014

The study included 16 children aged 7-17 years. The first stage of the treatment was endoimplantation of the DAM+ biopolymer. Stable positive effect (urine withholding under stress, lengthening of dry intervals from 1.4 to 3 hours, enlargement of the mean effective bladder volume) was documented in 12 patients. In four other cases, disorders of urination were characterized by enhanced loss of urine, decreased bladder capacity, and increased intravesical pressure. It is concluded that chemodenervation by botulinum toxin A is highly effective and can be regarded as the second stage of incontinence correction in the patients with myelodysplasia and intravesicle hypertension.

Cited by 0 works.

Authors